Company Overview
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.
Position Overview
Immunome is seeking a highly organized and service-oriented Office Manager to support day-to-day office operations and ensure a welcoming, efficient, and well-functioning workplace. This role is responsible for performing functional and administrative tasks that enable smooth office operations, including reception activities, resource coordination, and vendor management.
The Office Manager serves as a key point of contact for employees, visitors, and service providers, delivering excellent customer service and supporting a positive workplace experience. This role requires strong interpersonal communication skills, attention to detail, and the ability to manage multiple priorities in a fast-paced biotechnology environment.
Responsibilities
General Office Operations
- Serve as the primary point of contact for office reception and guest management, including greeting visitors, managing access, procuring badges, collecting NDAs, and escorting guests as needed.
- Coordinate incoming communications by monitoring the company phone line, directing calls appropriately, distributing mail, and assisting with general correspondence.
- Manage outgoing office shipping and mail requests.
- Coordinate catering for meetings, team lunches, and company events.
- Act as the primary contact for facilities-related service requests, including building management, janitorial services, and internal facilities support.
Resource & Vendor Management
- Maintain inventory of office supplies, amenities, and shared resources.
- Manage coffee, snacks, and common-area supplies to support employee needs.
- Coordinate with external vendors providing office services.
- Assist with conference room scheduling and meeting logistics.
- Provide backup support for laboratory shipping and receiving functions as needed.
Qualifications
- 1+ year of experience supporting facilities, operations, or administrative functions in a medium to large office environment.
- Experience in biotechnology, pharmaceutical, medical device, or other regulated environments strongly preferred.
Knowledge and Skills
- Excellent customer service skills with a professional and welcoming demeanor.
- Strong organizational skills and attention to detail.
- Ability to learn new systems and processes quickly.
- Effective communication and problem-solving abilities.
- Ability to manage multiple tasks and priorities simultaneously.
- Collaborative mindset and willingness to support team needs across functions.
- Proficiency with basic office software and scheduling tools.
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Top Skills
What We Do
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.






